| Literature DB >> 25504288 |
Awadhesh Pandit1, Vaibhav Jain1, Neeraj Kumar1, Arnab Mukhopadhyay1.
Abstract
Dietary restriction (DR) increases life span and delays the onset of age-related diseases across species. However, the molecular mechanisms have remained relatively unexplored in terms of gene regulation. InC. elegans, a popular model for aging studies, the FOXA transcription factor PHA-4 is a robust genetic regulator of DR, although little is known about how it regulates gene expression. We profiled the transcriptome and miRNAome of an eat-2 mutant, a genetic surrogate of DR, by Next Generation sequencing and find that most of the miRNAs are upregulated in the young-adult worms, none significantly downregulated. Interestingly, PHA-4 can potentially regulate the expression of most of these miRNA genes. Remarkably, many of the PHA-4-regulated genes that are induced during DR are also targets of the PHA-4-upregulated miRNAs, forming a large feed-forward gene regulatory network. The genes targeted by the feed-forward loops (FFLs) are enriched for functions related to ubiquitin-mediated decay, lysosomal autophagy, cellular signalling, protein folding etc., processes that play critical roles in DR and longevity. Together our data provides a framework for understanding the complex and unique regulatory network employed during DR, suggesting that PHA-4 employs such FFLs to fine-tune gene expression and instil robustness in the system during energy crisis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25504288 PMCID: PMC4247386 DOI: 10.18632/aging.100697
Source DB: PubMed Journal: Aging (Albany NY) ISSN: 1945-4589 Impact factor: 5.682
Figure 1Differential regulation of miRNA population in WT and eat-2(ad1116). A scatter plot of miRNAs commonly expressed between WT and eat-2(ad1116) in (A) day 1 young-adult worms or (B) aging day 8 worms. For this, we considered 120 (day 1) or 78 (day 8) miRNAs (see Table S3) that changed expression in eat-2(ad1116) as compared to WT and had read counts >10. (C) Validation of sequencing results by quantitative real-time PCR. The miRNA expresion of young-adult eat-2(ad1116) was compare to WT worms collected on day 1 of adulthood. Error bars indicate standard deviation between independent biological replicates. The p-values were calculated byt-test (* represent p < 0.05).
List of miRNAs that were significantly upregulated in young-adult/Day 1 eat-2(ad1116) worms as compare to WT (more details in Table S3)
| S. No. | miRNA | Fold Change | S. No. | miRNA | Fold Change | ||
|---|---|---|---|---|---|---|---|
| <0.0001 | 54 | 3.3 | <0.0001 | ||||
| 2 | 35.19 | <0.0001 | 55 | 3.29 | 0.0300 | ||
| 3 | 23.95 | 0.0008 | 56 | 3.22 | 0.0039 | ||
| <0.0001 | 57 | 3.16 | <0.0001 | ||||
| <0.0001 | <0.0001 | ||||||
| 6 | 20.59 | <0.0001 | 59 | 3.12 | <0.0001 | ||
| <0.0001 | 60 | 3.07 | <0.0001 | ||||
| 8 | 19.88 | <0.0001 | 61 | 3.07 | <0.0001 | ||
| 9 | 18.36 | <0.0001 | 62 | 3.05 | <0.0001 | ||
| 10 | 14.88 | <0.0001 | 63 | 3.03 | <0.0001 | ||
| 11 | 14.83 | <0.0001 | 64 | 2.93 | 0.0400 | ||
| 12 | 14.65 | <0.0001 | 65 | 2.88 | <0.0001 | ||
| 13 | 13.03 | <0.0001 | <0.0001 | ||||
| 14 | 12.78 | <0.0001 | 67 | 2.78 | 0.0400 | ||
| 15 | 12.6 | 0.0005 | 68 | 2.73 | <0.0001 | ||
| 16 | 12.42 | 0.0038 | 69 | 2.72 | <0.0001 | ||
| 17 | 11.92 | <0.0001 | 70 | 2.71 | <0.0001 | ||
| 18 | 10.85 | 0.0400 | 71 | 2.7 | <0.0001 | ||
| 19 | 10.67 | 0.0400 | 72 | 2.68 | 0.0060 | ||
| <0.0001 | 73 | 2.64 | <0.0001 | ||||
| 21 | 10.18 | 0.0100 | 74 | 2.54 | <0.0001 | ||
| 22 | 9.43 | <0.0001 | 75 | 2.45 | <0.0001 | ||
| 23 | 8.72 | <0.0001 | 76 | 2.3 | <0.0001 | ||
| 24 | 8.08 | <0.0001 | <0.0001 | ||||
| 25 | 7.07 | <0.0001 | 78 | 2.24 | 0.0100 | ||
| 26 | 6.53 | 0.0300 | 79 | 2.23 | <0.0001 | ||
| 27 | 6.43 | <0.0001 | 80 | 2.22 | 0.0100 | ||
| 28 | 6.17 | <0.0001 | 81 | 2.19 | <0.0001 | ||
| 29 | 6.07 | 0.0400 | 82 | 2.19 | 0.0064 | ||
| 30 | 5.03 | <0.0001 | 83 | 2.16 | 0.0037 | ||
| 31 | 5.03 | <0.0001 | 84 | 2.08 | 0.0400 | ||
| 32 | 4.88 | 0.0008 | 85 | 2.08 | 0.0006 | ||
| 33 | 4.87 | <0.0001 | 86 | 2.01 | <0.0001 | ||
| 34 | 4.74 | <0.0001 | 87 | 1.95 | 0.0019 | ||
| 35 | 4.37 | <0.0001 | 88 | 1.89 | 0.0036 | ||
| 36 | 4.32 | <0.0001 | 89 | 1.85 | <0.0001 | ||
| 37 | 4.07 | 0.0400 | 90 | 1.84 | 0.0006 | ||
| 38 | 4.07 | <0.0001 | 91 | 1.82 | <0.0001 | ||
| 39 | 4.04 | 0.0052 | <0.0001 | ||||
| 40 | 3.96 | <0.0001 | 93 | 1.8 | <0.0001 | ||
| 41 | 3.95 | 0.0200 | 94 | 1.73 | <0.0001 | ||
| 42 | 3.94 | 0.0001 | 95 | 1.72 | <0.0001 | ||
| 43 | 3.8 | 0.0005 | 96 | 1.71 | 0.0002 | ||
| 44 | 3.79 | 0.0400 | 97 | 1.70 | <0.0001 | ||
| 45 | 3.69 | 0.0001 | 98 | 1.70 | 0.0010 | ||
| 46 | 3.66 | <0.0001 | 99 | 1.69 | <0.0001 | ||
| 47 | 3.62 | <0.0001 | 100 | 1.68 | <0.0001 | ||
| 48 | 3.55 | <0.0001 | 101 | 1.68 | <0.0001 | ||
| 49 | 3.55 | 0.0002 | 102 | 1.61 | <0.0001 | ||
| 50 | 3.5 | <0.0001 | 103 | 1.51 | <0.0001 | ||
| 51 | 3.4 | <0.0001 | 104 | 1.50 | <0.0001 | ||
| 52 | 3.4 | 0.0041 | 105 | 1.50 | 0.0500 | ||
| 53 | 3.32 | <0.0001 |
MiRNAs that were used for QRT-PCR validation are in bold.
MiRNAs that did not possess any PHA-4 binding peaks are indicated in red. All the other miRNAs had one or more binding peaks within 5 kb upstream and 1 kb downstream of the transcription start site.
Figure 2Age-dependent changes in miRNA expression. (A) A Heatmap showing expression patterns of 152 miRNAs that are commonly expressed in WT and eat-2(ad1116) at day 1 (young-adults) and day 8 (aging worms) of adulthood. The miRNAs are grouped into distinct clusters A-G based on the similarity in their expression patterns. (B) A Heatmap comparing the expression of miRNAs in WT, eat-2(ad1116) and daf-2(e1370).
Figure 3Expression of novel miRNAs during DR. (A) The secondary structures of 3 predicted novel miRNA candidates as generated using the miRDeep2 program. (B) Expression of predicted novel miRNAs were examined in specific Argonaut gene mutants alg-1(gk214) or alg-2(ok304) by QRT-PCR (C) Expression changes of novel miRNAs in eat-2(ad1116) as compare to WT collected on day 1 of adulthood (young-adult worms) by qRT-PCR. Error bars indicate Standard Deviation between independent biological replicates. The p-values were calculated by t-test (* represents p < 0.05).
Figure 4The miRNAs and mRNAs upregulated during DR are potential direct targets of PHA-4. (A) QRT-PCR analysis shows the expression levels of the miRNAs in eat-2(ad1116);rrf-3(pk1246) compared to rrf-3(pk1246), when grown on control or pha-4 RNAi. (B) QRT-PCR analysis showing the expression levels of predicted PHA-4 direct target genes in eat-2(ad1116);rrf-3(pk1246) compared to rrf-3(pk1246), grown either on control and pha-4 RNAi. The error bars represent Standard Deviation between independent biological samples. ‘ns’ represents p ≥ 0.05 by t-test.
Figure 5PHA-4 controls a large number of genes by feed-forward loops using miRNAs. (A) A representation of transcription factor-miRNA feed forward loop involving PHA-4 that controls life span during DR. (B) A complex regulatory network involving PHA-4 and its target mRNAs that are also regulated by PHA-4-controlled miRNAs. The network was generated using Cytoscape v3.1.1. Only a subset of genes targeted by PHA-4-regulated miRNA [as determined by mirTarBase were used to generate a representative decongested network. The boxes corresponding to the miRNA or mRNA/genes are colored based on their fold induction in eat-2(ad1116) as compared to WT. Edges are colored based on the number of miRNAs regulating a particular gene. Dark red are for genes regulated by 20 or more miRNAs while those regulated by less than 10 miRNAs are in black. MiRNAs that have no target listed in mirTarBase are in red. (C) The genes targeted by PHA-4 transcriptionally as well as post-transcriptionally are highly connected by protein-protein interactions, as determined by STRING software.
Figure 6Genes regulated by PHA-4,transcriptionally as well as post-transcriptionally using miRNA are involved in important biological functions during DR. (A) The 1073 genes are enriched in GO terms pertaining to protein folding, cellular metabolism and response to external stimuli. GO analysis was performed using GORILA software and visualized with REVIGO. (B) KEGG pathway components for signaling, lysosome and ubiquitin-mediated decay are enriched in genes that are regulated by PHA-4-controlled FFLs.
List of aging-associated genes that are transcriptionally as well as post-transcriptionally regulated by PHA-4
| Gene Name | Effect on lifespan | Functions |
|---|---|---|
| Increase | Acyl CoA DeHydrogenase | |
| Increase | AKT kinase family | |
| Increase | AdaPtin, Small chain (clathrin associated complex) | |
| Decrease | BEClin (human autophagy) homolog | |
| Increase | - | |
| Increase | KH domain-containing protein | |
| Decrease | CCR (yeast CCR4/NOT complex component) homolog | |
| Increase | Chromo domain-containing protein | |
| Decrease | Homeobox containing protein | |
| Decrease | Clathrin Heavy Chain | |
| Decrease | CU (copper) ATPase | |
| Increase | A member of the steroid hormone receptor superfamily | |
| Increase | Possibly a transducer of the DAF-7/TGF-beta-mediated signal that promotes reproductive growth | |
| Decrease | Forkhead family transcription factor | |
| Decrease | Transcriptional regulator | |
| Increase | Transmembrane serine/threonine kinase | |
| Decrease | DAF-12 Interacting Protein | |
| Decrease | DAP (Death Associated Protein kinase) Like Kinase | |
| Decrease | ATP-binding protein that is a homolog of the SMC4 subunit of mitotic condensin | |
| Decrease | DVE (Defective proVEntriculus in Drosophila) homolog | |
| Increase | GATA family transcription factor | |
| Increase | Homolog of human MTA1 (metastasis-associated protein), a part of a nucleosome remodeling and histone deacetylation (NURD) complex | |
| Increase | phospholipase C beta | |
| Increase | Proline hydroxylase | |
| Increase | Enhancer of PolyComb-like | |
| Increase | Ezrin/Radixin/Moesin | |
| Increase | ETS class transcription factor | |
| Increase | - | |
| Increase | DNA-directed RNA polymerase | |
| Increase | Guanylyl CYclase | |
| Decrease | GEX Interacting protein | |
| Decrease | Homeodomain interacting Protein Kinase | |
| Decrease | IRE1 kinase related | |
| Increase | Inositol Triphosphate Receptor | |
| Decrease | - | |
| Decrease | human KRIT 1 (Krev interaction trapped/cerebral cavernous malformation 1) homolog | |
| Decrease | LIM domain Binding Protein | |
| Increase and Decrease | EGF-receptor-family transmembrane tyrosine kinase | |
| Decrease | Rho-binding Ser/Thr kinase, orthologous to human myotonic dystrophy kinase (DM-kinase) | |
| Increase | Member of the GTP-binding RAS protooncogene family | |
| Decrease | Novel protein that contains a THAP domain, a zinc-coordinating, site-specific DNA-binding domain | |
| Decrease | F-box- and WD-repeat-containing protein, components of SCF (Skp1, Cullin, F-box) ubiquitin-ligase complexes that function in ubiquitin-mediated protein degradation | |
| Decrease | EGF family of peptide growth factors | |
| Increase | - | |
| Increase | Motor AXon guidance | |
| Decrease | Mog interacting, Ectopic P granules | |
| Increase | Mitoferrin | |
| Decrease | MAP kinase iNtegrating Kinase (MNK) homolog | |
| Increase | Temporarily Assigned Gene name | |
| Increase | Multidrug Resistance Protein family | |
| Decrease | MTM (myotubularin) family | |
| Increase | NADC (Na+-coupled dicarboxylate transporter) family | |
| Decrease | Transcription/replication factor | |
| Increase | Nuclear Hormone Receptor family | |
| Increase | Nuclear Hormone Receptor family | |
| Decrease | Nuclear Hormone Receptor family | |
| Increase | Na/H eXchanger | |
| Increase | Na-K-Cl Cotransporter homolog | |
| Increase | Fatty acids and vitamin A binding | |
| Increase | PolyA Binding protein | |
| Increase | Poly(U) Polymerase | |
| Increase | - | |
| Decrease | RAB family | |
| Decrease | RB (Retinoblastoma Binding protein) Related | |
| Increase | Replication Protein A homolog | |
| Increase | Suppressor/Enhancer of Lin-12 | |
| Increase | SET (trithorax/polycomb) domain containing | |
| Decrease | SET (trithorax/polycomb) domain containing | |
| Increase | Serum- and Glucocorticoid-inducible kinase homolog | |
| Increase | Suppressor with Morphological effect on Genitalia | |
| Decrease | SMEK (Dictyostelium Suppressor of MEK null) homolog | |
| Decrease | Required cell autonomously in neurons for differentiation of presynaptic active zones | |
| Increase | Required for inhibition and adaptation of several sensory neurons and for the normal regulation of egg-laying by serotonin | |
| Increase | Temporarily Assigned Gene name | |
| Decrease | TOPoisomerase | |
| Increase | Encodes synaptojanin, a polyphosphoinositide phosphatase | |
| Increase | Vacuolar H+-ATPase V0 sector, subunit a | |
| Increase | Basement-membrane (HSPG) core | |
| Increase | Meis-class homeodomain protein | |
| Increase | Encodes FEZ family protein involved in axon-axon interactions | |
| Increase | WD Repeat protein | |
| Decrease | Wiskott-Aldrich syndrome protein (WASP)-Interacting Protein and gene assignment | |
| Increase | WarTS (Drosophila) protein kinase homolog | |
| Decrease | WW domain Protein (E3 ubiquitin ligase) | |
| Increase | Ribosome biogenesis | |
| Decrease | leucine zipper, zinc finger, and PHD/LAP domain protein |